New England Capital Financial Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.3K | Hold |
1,120
| – | – | 0.04% | 87 |
|
|
2025
Q1 | $82.4K | Hold |
1,120
| – | – | 0.04% | 87 |
|
|
2024
Q4 | $73.4K | Hold |
1,120
| – | – | 0.04% | 93 |
|
|
2024
Q3 | $87.3K | Hold |
1,120
| – | – | 0.05% | 86 |
|
|
2024
Q2 | $87.4K | Hold |
1,120
| – | – | 0.05% | 80 |
|
|
2024
Q1 | $75.9K | Sell |
1,120
-697
| -38% | -$47.2K | 0.04% | 86 |
|
|
2023
Q4 | $122K | Hold |
1,817
| – | – | 0.07% | 65 |
|
|
2023
Q3 | $123K | Sell |
1,817
-688
| -27% | -$46.6K | 0.08% | 61 |
|
|
2023
Q2 | $179K | Buy |
2,505
+1,385
| +124% | +$99.1K | 0.12% | 55 |
|
|
2023
Q1 | $77.8K | Hold |
1,120
| – | – | 0.05% | 86 |
|
|
2022
Q4 | $77.5K | Buy |
+1,120
| New | +$77.5K | 0.05% | 86 |
|